<DOC>
	<DOCNO>NCT00694824</DOCNO>
	<brief_summary>A randomize , cross sectional study do determine possible association coronary artery calcification ( CAC ) score assess multirow spiral compute tomography ( MSCT ) specific non specific uremic factor vascular calcification .</brief_summary>
	<brief_title>Vascular Calcification 's Risk Factors Haemodialysis Patients</brief_title>
	<detailed_description>Cardiovascular disease ( CVD ) main cause death hospitalization patient affect ESRD . The risk death CVD already detectable early step chronic renal failure 20 30 time higher general population . In ESRD patient traditional risk factor CVD offer satisfactory explanation high mortality morbidity rate . Among , calcium-phosphate imbalance , inflammation , dialysis age , anaemia , hyperhomocysteinemia , oxidative stress , malnutrition , high lipoprotein level endothelial dysfunction consider ( 4 ) . Recently attention pay calcium phosphate imbalance involve either presence progression vascular calcification ( VC ) ESRD patient . Multiple factor notice contribute VC mineral metabolism : use calcium-based phosphate binder , diabetes , age , inflammation , cytokine BMI . Indeed believe arterial calcification active process involve phenotypic transformation vascular smooth muscle cell ( VSMC ) bone-forming osteoblast ( ob ) -like cell capable express and/or release bone matrix proteins necessary support calcification process : OPG , RANKL , OPN , fetuin A MGP . Several stimulus , first mineral change show induce modulate phenotypic transformation . Indeed expression secretion above-mentioned protein regulate several molecule TGF β , peroxisome proliferator-activated receptor ( PPAR ) γ , tumor necrosis factor ( TNF ) α. Calcification develop two site arterial wall , intima medium layer : 1 ) intimal calcification frequent advance stage atherosclerosis associate plaque rupture occlusion vessel ; 2 ) calcification medium layer , Mockenberg 's sclerosis , observe capacitance vessel muscular vessel , cause arterial stiffness high pulse pressure , independent risk factor mortality ESRD patient . Both type calcification important impact term morbidity mortality patient ESRD especially calcification pattern affect coronary artery . It often difficult evaluate calcification process mainly locate intima , medium . New image technique recently use order reliably detect objectively measure extent vascular calcification . These technique include use electron beam compute tomography ( EBCT ) MSCT quantify coronary artery calcification ( CAC ) . The degree calcification within coronary artery measure obtain calcium score . Recently , several study analyze correlation VC inhibitor promoter cardiovascular disease VC . In particular , study analyse role fetuin A , MGP , OPG , OPN . Just study involve uremic patient consider inhibitory factor individually . The aim study evaluate cohort 253 patient , possible association CAC score assess MSCT risk factor VC . We select 253 chronic hemodialysis patient among undergoing hemodialysis Nephrology Dialysis Renal Transplantation Unit , S.Orsola University Hospital , Bologna , Italy April 2003 March 2008 . All patient start dialysis least 6 month begin study . All patient consider gender , age start dialysis , month hemodialysis , length period start chronic renal failure onset begin dialysis , BMI , blood arterial pressure , tobacco abuse . The mean age 62.5 ± 13.5 year , mean dialysis age 41.6 ± 62.8 month . For patient blood sample drawn check basal value hemoglobin , hematocrit , folate , vitamin B12 , C reactive protein , PTH , calcium , phosphorus , albumin , alkaline phosphatase , total cholesterol , HDL cholesterol , LDL cholesterol , triglyceride , uric acid , fibrinogen , homocysteine . To good understand mineral metabolism TGFb1 , fetuin A , OPG , FGF 23 , OPN MGP check . The value patient median 4 determination , sample drawn midweek dialysis session . The period exposure calcium phosphate product major 55 mg/dl also evaluate patient ( day CaxP &gt; 55 ) . For measure maximum phosphate value consider , patient assume calcium base phosphate binder measure calcium phosphate product obtain consider period maximum oral assumption drug . Furthermore calcium phosphate product assess monthly , period dialysis begin study , time measure exceed 55 mg/dl ( n CaxP &gt; 55 ) record . In way assessed period exposure phosphate concentration &gt; 6 mg/dl time marker exceed 6 mg/dl . The kind phosphate binder record focus different association drug commercially available . The cardiovascular status patient strictly define score range 0 2 patient : 0 absence cardiovascular event patient clinical history , 1 one VC event , 2 two cardiovascular event . As regard cardiovascular disease screen , evaluate follow : presence absence ischemic cardiomyopathy , cerebral peripheral vasculopathy . Coronary artery disease check mean one follow parameter : 1 ) previous documentation acute myocardial infarction ; 2 ) symptomatic VC event clinical history confirm positive treadmill test ; 3 ) coronary artery stenosis 50 % one three major coronary vessel document angiographic study . Cerebrovascular disease investigate one follow criterion : 1 ) previous ictus cerebri ; b ) carotid vessel stenosis 50 % document Doppler exam . Peripheral vascular disease assess evidence claudication intermittens , previous surgical procedure , angiographic Doppler documentation significative stenosis abdominal , iliac femoral vessel . All patient undergo MSCT determination coronary vascular calcification assessment calcium score . Instrumental evaluation coronary vascular calcification quantification coronary calcium score obtain mean Somatom Sensation 16 Cardiac ( Siemens Farcheim , Germany ) , calcium score assess mean specific software ( Syngo Ca-score , Siemens ) accord Agatston system ( 18 ) . Patients also group mean member cardiovascular event mean serum biochemistry bone turnover ass difference might emerge . A group patient obtain BMI divide patient BMI &lt; 18.5 , BMI 18.5 30 30 consider possible difference calcium score .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<criteria>All patient start dialysis least 6 month Recent infectious cardiovascular disease last month enrollment study ; Malignancies ; Active bleeding ; Therapy ace inhibitor angiotensin II block drug ; Enrollment study protocol ; Bone fracture last year ; Paget 's disease ; Bisphosphonate therapy . Inflammation active process</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Coronary artery calcification</keyword>
	<keyword>calcium score</keyword>
	<keyword>( TGF ) b1 ,</keyword>
	<keyword>fetuin A</keyword>
	<keyword>osteoprotegerin ( OPG )</keyword>
	<keyword>fibroblast growth factor ( FGF ) 23 ,</keyword>
	<keyword>matrix gla protein ( MGP )</keyword>
	<keyword>hemodialysis patient</keyword>
</DOC>